Ransomware Intelligence

    Latest Research on INC and The Gentlemen Ransomware: Exposed AI Infrastructure

    Read the Research

    KABS Pharmaceutical Services Ransomware Attack

    kabs.comRansomed

    CanadaCountry
    Nov 2, 2026Discovered

    About this victim

    kabs.com Revenue $27.2 Million KABS Laboratories is a Canadian pharmaceutical CDMO founded in 1997 in Saint-Hubert, Quebec by Dr. Jean-Simon Blais and Dr. Gérard Akinocho, with 150+ specialists serving clients in 28 countries. It is a WHO prequalified Quality Control Laboratory audited by Health Canada, USFDA and EU QPs, offering aseptic manufacturing from 100 to 100,000 vials per batch. In 2021 it received CAD 54.2 million from Canada's Strategic Innovation Fund to expand fill-and-finish to 30 million vials per year and build a bioprocessing plant for monoclonal antibodies. Through joint venture MendeliKABS it developed MDK-Nitisinone, an orphan drug for tyrosinemia type 1, priced 10 times lower than the Swedish competitor and approved in Europe, UK, Brazil, China and Algeria. The company also runs an African quality control office in Benin.

    Domain

    kabs.com

    Industry

    Healthcare

    Country

    Canada

    Discovered

    15 days ago

    Attack date

    Nov 2, 2026

    Confidence

    70%

    Severity

    Medium

    Status

    Claimed

    Threat group

    thegentlemen

    Total victims

    1,114

    First seen

    Nov 2025

    Last seen

    Nov 2026

    Group status

    active

    Sophistication

    0

    Impact score

    111

    Threat level

    7.1/10
    Aggressiveness10/10
    Lethalityn/a
    Criticality3.8/10

    Status breakdown

    Data Leaked0.4%5
    Negotiating0.3%3
    Claimed
    this victim
    99.3%1,106

    Victim's position within group

    Industry

    Healthcare

    Known target sector

    Country

    Canada

    Frequently targeted country

    Group activity

    Monthly attacks · thegentlemen

    1,114

    total · avg 85.7/mo